Patent & history
Issued U.S. patents, PCT and CIPO family records, later treating-water pre-grants, and the JOHN ELLIS WATER trademark file.
Independent primary-source archive
Follow the record, not the lore.
John Ellis water patents document distillation and water-degasification apparatuses and methods. They do not prove medical benefit, certify safety, or validate later health advertising. U.S. and PCT publications from 1982 onward are legal and technical records of what was filed. Company-hosted lab PDFs remain first-party claims until independently authenticated. The April 28, 2020 FTC action was a warning letter about unsupported COVID-19 prevention or treatment advertising, not a court judgment. This archive records that distinction and gives no treatment advice.
The Patent File
The characteristic desk on this archive. Pull a leaf from the patent drawer or the health-claim drawer and read the stamp: what the paper establishes, and what it does not. Then stamp eight statements yourself. No treatment advice. No new clinical claims.
Health claims
Company-hosted lab PDFs, charts, and advertising — including COVID-era claims described by the FTC — classified as first-party representation.
Regulatory
The April 28, 2020 FTC warning letter, kept as a warning letter rather than a court judgment or shutdown.
Open the file →Three kinds of evidence
The archive keeps unlike materials unlike. A patent, a company-hosted laboratory document, and an agency warning letter answer different questions and carry different evidentiary weight.
What was filed
USPTO, WIPO, CIPO, and trademark records document applications, claims, dates, and legal status. They do not independently prove performance.
Patent lineage →What was claimed
Company pages, product instructions, and site-hosted test documents establish what was presented publicly—not whether the claims were independently validated.
Claims and testing →What the FTC said
The April 2020 warning letter documents staff concerns about unsupported COVID-19 prevention or treatment advertising. It was a warning letter, not a court judgment.
Regulatory record →What the record establishes
The collected documents support a narrow, defensible account. The archive avoids extending them beyond what they actually show.
A documented patent lineage
Issued U.S. patents describe distillation and water-degasification apparatuses and methods across two decades.
Later treatment applications
Three pre-grant publications extend the documentary trail into later “treating water” applications.
Independent efficacy evidence
The archive has not established independent, well-controlled evidence for medical or broad product-efficacy claims.
Do not infer efficacy from filing status.
Patent examination concerns patentability. It is not a safety certification, product approval, or independent experimental replication. This site offers no medical or water-safety advice.
Start with the strongest trail
Read the evidence chronologically, then check the archive’s labels and limitations before drawing a conclusion.
Stamp the Patent File
Separate patent history from health claims at the docket desk before reading the lore in either direction.
Open the Patent File →Inspect direct records
Follow official FTC, USPTO, WIPO, CIPO, and first-party links with provenance notes.
Open sources →Check the method
Understand the archive’s evidence labels, capture date, copyright boundary, and unresolved questions.
Read methodology →